US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARIAD Pharmaceuticals

23.99

+0.0000

Volume:- -

Turnover:- -

Market Cap:4.66B

PE:-133.28

High:23.99

Open:23.99

Low:23.99

Close:23.99

Loading ...

Overview Company News Filings

AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome

Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update

Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24

ARIA Cybersecurity enters reseller partnership with CED

ARIA Cybersecurity Solutions Partners with CED to Protect Rockwell Automation Customers from Dangerous Cyberattacks

F500 Electric Energy Producer Selects ARIA AZT PROTECT(TM) to Stop Malicious Cyberattacks

Press Release: Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results

Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality

Lexeo Therapeutics Announces Positive Interim Data for LX1001, First-Ever Gene Therapy to Impact the Underlying Genetic Cause of APOE4-Associated Alzheimer’s Disease, at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Eli Lilly says Donanemab redudced ARIA-E in early Alzheimer’s patients

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ARIA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARIA\",,,,,undefined,":{"symbol":"ARIA","market":"US","secType":"STK","nameCN":"ARIAD Pharmaceuticals","latestPrice":23.99,"timestamp":1745341919974,"preClose":23.99,"halted":0,"volume":0,"delay":0,"floatShares":169700000,"shares":194200862,"eps":-0.18,"marketStatus":"Trading","change":0,"latestTime":"04-22 13:11:59 EDT","open":23.99,"high":23.99,"low":23.99,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.18,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":23.99,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARIA\",,,,,undefined,":{"symbol":"ARIA","floatShares":169700000,"roa":"--","roe":"--","lyrEps":0,"shares":194200862,"dividePrice":0,"high":23.99,"amplitude":0,"preClose":23.99,"low":23.99,"week52Low":23.99,"pbRate":"-100.52","week52High":23.99,"institutionHeld":0.5771,"latestPrice":23.99,"eps":-0.18,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.18,"open":23.99,"prevYearClose":23.99,"prevWeekClose":23.99,"prevMonthClose":23.99,"prevQuarterClose":23.99,"fiveDayClose":23.99,"twentyDayClose":23.99,"sixtyDayClose":23.99},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARIA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490944020","title":"AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2490944020","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490944020?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:00","pubTimestamp":1733832000,"startTime":"0","endTime":"0","summary":"AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome  ACI-24.060 was generally safe and well tolerated in individuals with Down syndrome with no serious adv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/10/2994352/0/en/AC-Immune-Reports-Interim-Safety-Data-from-Phase-1b-2-ABATE-Trial-of-ACI-24-060-in-Down-syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AC","BK4135","BK4588","BK4113","BK4192","PET","ARIA","ACIU","BK4023","BK4539","ACI","BK4585"],"gpt_icon":1},{"id":"2486689420","title":"Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2486689420","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486689420?lang=en_us&edition=fundamental","pubTime":"2024-11-26 05:05","pubTimestamp":1732568700,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Nov.  25, 2024  (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering novel, genetically validated therapies for the treatmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/25/2987062/0/en/Alector-Announces-Results-from-AL002-INVOKE-2-Phase-2-Trial-in-Individuals-with-Early-Alzheimer-s-Disease-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARIA"],"gpt_icon":0},{"id":"2486103082","title":"Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24","url":"https://stock-news.laohu8.com/highlight/detail?id=2486103082","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486103082?lang=en_us&edition=fundamental","pubTime":"2024-11-25 22:00","pubTimestamp":1732543200,"startTime":"0","endTime":"0","summary":"MR technologist reviews icometrix AI report on the Philips BlueSeal MRI console. MR technologist reviews neuro images in icometrix AI reporting tool","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wecs83zku_6o93gqBi6ogw--~B/aD0xMzExO3c9MTk2NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/ece46406c470c576582a50a555c301fe","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wecs83zku_6o93gqBi6ogw--~B/aD0xMzExO3c9MTk2NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/ece46406c470c576582a50a555c301fe"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/philips-icometrix-advance-precision-diagnosis-140000285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","LU1363072403.SGD","LU2089283258.USD","BK4516","BK4581","LU2357305700.SGD","LU1720051108.HKD","BK4585","LU2028103732.USD","LU0158827948.USD","LU1548497426.USD","PHG","LU2023251221.USD","BK4504","IE00BZ1G4Q59.USD","LU0006306889.USD","LU0225283273.USD","LU1989772840.SGD","LU1162221912.USD","LU0320765646.SGD","LU0971096721.USD","BK4082","ARIA","LU1668664300.SGD","LU1989772923.USD","LU0098860793.USD","LU2271345857.HKD","LU0106831901.USD","LU0158827781.USD","BK4127","BK4588","IE00BKVL7J92.USD","LU1720051017.SGD","LU0314104364.USD","LU2089284900.SGD","LU0267386448.USD","LU0106261372.USD","LU1074936037.SGD","LU2111349929.HKD"],"gpt_icon":0},{"id":"2486820084","title":"ARIA Cybersecurity enters reseller partnership with CED","url":"https://stock-news.laohu8.com/highlight/detail?id=2486820084","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486820084?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:21","pubTimestamp":1732540870,"startTime":"0","endTime":"0","summary":"ARIA Cybersecurity Solutions announced a new reseller partnership with CED Industrial Solutions Network a provider of Rockwell Automation sofware a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aria-cybersecurity-enters-reseller-partnership-with-ced?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aria-cybersecurity-enters-reseller-partnership-with-ced?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARIA"],"gpt_icon":0},{"id":"2486084350","title":"ARIA Cybersecurity Solutions Partners with CED to Protect Rockwell Automation Customers from Dangerous Cyberattacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2486084350","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486084350?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:00","pubTimestamp":1732539600,"startTime":"0","endTime":"0","summary":"BOSTON, MA / ACCESSWIRE / November 25, 2024 / ARIA Cybersecurity Solutions, a CSPi business  a leading provider of cybersecurity solutions announced a new reseller partnership with CED Industrial Solutions Network an industry-leading provider of Rockwell Automation software and equipment in the US.ARIA's AZT PROTECT zero-trust solution provides a lock-down approach to protecting critical infrastructure applications from attack, with a focus on stopping all forms of malware, ransomware, as well as nation-state-backed attacks on these applications and the OS on which they run.ARIA is working with CED to resell AZT PROTECT into their customers' Rockwell Automation systems to better protect them from today's cyberattacks.ARIA Cybersecurity Solutions, a business of CSPi Inc. NASDAQ:CSPI, recognizes that better, stronger, more effective cybersecurity starts with a smarter approach. Our solutions provide new ways for organizations to protect their most critical assets-they can shield their cr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aria-cybersecurity-solutions-partners-ced-130000857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4580","BK4096","ARIA","BK4211","LU0390134368.USD","LU0154245673.USD","CUBI","BK4588","ROK","CSPI","BK4134","LU0154245756.USD","BK4585"],"gpt_icon":0},{"id":"2485496687","title":"F500 Electric Energy Producer Selects ARIA AZT PROTECT(TM) to Stop Malicious Cyberattacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2485496687","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485496687?lang=en_us&edition=fundamental","pubTime":"2024-11-21 21:00","pubTimestamp":1732194000,"startTime":"0","endTime":"0","summary":"Large growing independent retail energy producer begins to deploy ARIA AZT PROTECT across its footprint of over 30 plants. BOSTON, MA / ACCESSWIRE / November 21, 2024 / ARIA Cybersecurity Solutions, a CSPi business  a leading provider of cybersecurity solutions announced a new customer in the energy sector.ARIA's AZT PROTECT zero trust solution provides a lock-down approach to protecting critical infrastructure applications from attack, focusing on stopping all forms of zero-day malware, ransomware as well as nation-state-backed attacks on these applications and the operating systems on which they run. Ensuring the highest level of protection for critical infrastructure.ARIA Cybersecurity Solutions, a business of CSPi Inc. NASDAQ: CSPI, recognizes that better, stronger, more effective cybersecurity starts with a smarter approach. Our solutions provide new ways for organizations to protect their most critical assets-they can shield their critical applications from attack with our AZT PR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/f500-electric-energy-producer-selects-130000632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TM","BK4099","ARIA","CSPI","BK4585","BK4555","BK4134","BK4588","03160"],"gpt_icon":1},{"id":"2483013670","title":"Press Release: Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483013670","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483013670?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:30","pubTimestamp":1731501000,"startTime":"0","endTime":"0","summary":"Reached alignment with FDA on key elements of registrational development plan for LX2006, including accelerated approval pathway with left-ventricular mass index  and frataxin protein expression as co-primary registrational endpoints. Received RMAT designation for LX2006 for the treatment of Friedreich ataxia  cardiomyopathy, potentially enabling expedited development and increased interaction with the FDA. Completed enrollment of LX2006 SUNRISE-FA Phase 1/2 trial, with four participants treated in cohort 3; total of 16 participants dosed with LX2006 to date across SUNRISE-FA and Weill Cornell trials. Completed enrollment of cohort 1 of LX2020 HEROIC-PKP2 Phase 1/2 trial; initial clinical data including safety and biodistribution on track for late Q1 / early Q2 2025","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4535","FA","LXEO","BK4162","IHC","BK4130","ARIA"],"gpt_icon":0},{"id":"2481593799","title":"Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2481593799","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481593799?lang=en_us&edition=fundamental","pubTime":"2024-11-07 05:01","pubTimestamp":1730926860,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Nov.  06, 2024  (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the third quarter ended September 30, 2024, and provided b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/06/2976005/0/en/Denali-Therapeutics-Reports-Third-Quarter-2024-Financial-Results-and-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARIA","ETV","LU1169590202.USD","BK4023","LU1169589451.USD","BK4139","TV","LENZ","PD","BK4100"],"gpt_icon":0},{"id":"2479821610","title":"Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality","url":"https://stock-news.laohu8.com/highlight/detail?id=2479821610","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479821610?lang=en_us&edition=fundamental","pubTime":"2024-10-31 21:00","pubTimestamp":1730379600,"startTime":"0","endTime":"0","summary":"Today’s presentation at CTAD, a leading international Alzheimer's conference, expands research supporting the value of ultra-low-field MRI in monitoring amyloid-related imaging abnormalities .The presentation today at CTAD featured research from Washington University in St. Louis, a leading center in Alzheimer’s disease research using ultra-low-field MR imaging with the Swoop system and an actively enrolling center in the CARE PMR study. The authors shared their experiences using Swoop system images to detect ARIA-E in patients undergoing Lecanemab therapy. The presentation showcased multiple cases comparing images obtained with the ultra-low-field Swoop portable MR brain imaging system with images from a high-field 3 tesla MRI scanner. The Swoop system images, processed using the latest advancements in AI-driven research software, demonstrated impressive image quality that shows promise for use in assisting physicians in detecting ARIA-E.Dr. Edmond Knopp, Chief Medical Officer at Hype","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/l4BGcsOwh8K_0XGgVjX0eA--~B/aD0zMjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/095686d38f67e210e7470b9c6fde3c64","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/l4BGcsOwh8K_0XGgVjX0eA--~B/aD0zMjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/095686d38f67e210e7470b9c6fde3c64"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hyperfine-announces-alzheimer-research-promising-130000678.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4110","IE00B66KJ199.SGD","HYPR","ARIA","BK4082","AEIS","IE0031619046.USD","BK4157","IE00B7SZL793.SGD","IE00B19Z4B17.USD","AAIC"],"gpt_icon":0},{"id":"2479271966","title":"Lexeo Therapeutics Announces Positive Interim Data for LX1001, First-Ever Gene Therapy to Impact the Underlying Genetic Cause of APOE4-Associated Alzheimer’s Disease, at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2479271966","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479271966?lang=en_us&edition=fundamental","pubTime":"2024-10-30 18:14","pubTimestamp":1730283240,"startTime":"0","endTime":"0","summary":"Dose-dependent increase in neuroprotective APOE2 expression in all participants with ongoing durability at 12 months Consistent reductions across CSF tau biomarkers and tau PET in majority of particip","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/30/2971504/0/en/Lexeo-Therapeutics-Announces-Positive-Interim-Data-for-LX1001-First-Ever-Gene-Therapy-to-Impact-the-Underlying-Genetic-Cause-of-APOE4-Associated-Alzheimer-s-Disease-at-the-Clinical.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCI","ARIA","BK4121","CSF","BK4139","LXEO","GENE"],"gpt_icon":0},{"id":"2479523683","title":"Eli Lilly says Donanemab redudced ARIA-E in early Alzheimer’s patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2479523683","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479523683?lang=en_us&edition=fundamental","pubTime":"2024-10-30 00:20","pubTimestamp":1730218815,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) announced “positive results” from the TRAILBLAZER-ALZ 6 Phase 3b study, showing a reduction in amyloid-related imaging abnormalitie...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-says-donanemab-redudced-aria-e-in-early-alzheimers-patients?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-says-donanemab-redudced-aria-e-in-early-alzheimers-patients?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LLY","LU0471298777.SGD","LU0096364046.USD","LU1023059063.AUD","LU0109391861.USD","LU1061106388.HKD","GB00BDT5M118.USD","LU0471298694.HKD","IE00B1BXHZ80.USD","LU0079474960.USD","LU0114720955.EUR","LU0061475181.USD","LU1093756168.USD","LU0097036916.USD","BK4581","LU0198837287.USD","LU0385154629.USD","LU0823416689.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0106261372.USD","BK4533","LU0203201768.USD","LU0882574139.USD","LU0256863811.USD","LU0672654240.SGD","LU1035775433.USD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU1064131342.USD","LU0882574055.USD","LU0320765059.SGD","IE00BK4W5M84.HKD","IE00B4R5TH58.HKD","LU0640476718.USD","IE0004445239.USD","IE0002141913.USD","LU1057294990.SGD","LU0820561818.USD","LU0256863902.USD","IE00BK4W5L77.USD","IE00BFTCPJ56.SGD","BK4516","IE0009355771.USD","LU1069344957.HKD","IE00B2B36J28.USD","ARIA","LU0456855351.SGD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARIA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-11-07","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1478494800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-07-28","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1469678400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-10","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1462852800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-02-23","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1456203600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2015-11-03","symbol":"ARIA","fiscalQuarterEnding":null,"expectedEps":-0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1446526800000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARIA\",market:\"US\",delay:false,,,undefined,":{}}}